If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
385.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 30.00 (8.108%)
Market Cap: £36.79m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Trading Update

8 Mar 2021 07:00

RNS Number : 4015R
Cropper(James) PLC
08 March 2021
 

Cropper(James) PLC

 

8 March 2021

James Cropper plc ("James Cropper" or the "Company")

Trading update

 

James Cropper PLC, the advanced materials and paper products group, is pleased to issue a positive trading update for the 52 weeks to 27 March 2021.

As reported in the half year results to 26 September 2020, the first half of the year had been particularly challenging due to the significant impact of the Covid-19 pandemic. The Group responded quickly to the challenges taking swift action to protect staff, reduce costs, optimise cash flow and protect liquidity. All divisions of the Group were affected to varying degrees by the pandemic. Since the half year, trading has improved, and the restructuring program is now complete.

In January 2021, the TFP division acquired PV3 Technologies Limited, a company specialising in the development and manufacture of electrochemical materials used in the creation of hydrogen. The acquisition is the latest step in TFP's growth plans, providing the opportunity to further enhance TFP's market position in the hydrogen economy. Following the suspension of all major capital expenditure in H1 due to the pandemic, work on installing the additional production line has now recommenced and is expected to be complete in summer of 2021.

Colourform's rate of growth has been impacted by a pandemic related downturn within the beauty and spirit sectors. Nonetheless, it is expected that revenues will be up on the previous year.

The Paper division endured the biggest impact from the pandemic as a result of global lockdowns affecting demand for luxury packaging, education and event collateral. In the first half, revenues were 45% down, compared to the comparable period last year, with the reduced demand leading to periods of inefficient or no production. Revenues in H2 have improved but expected to be 20% down compared to the comparable period last year.

The Company acted promptly at the start of the pandemic to conserve cash and implement immediate savings. It has good headroom against all its banking covenants and is in a strong financial position with liquidity of over £18 million from cash, overdraft and other available facilities including a £4m loan from the Coronavirus Large Business Interruption Loan Scheme. This is expected to be sufficient for the Company to return to more normal trading conditions, to invest and to emerge from the pandemic stronger.

Due to the improving trading performance and continued operational focus the Board expects the results for the year ending 27 March 2021 to be improved from previous expectations. The profit for the year ending 27 March 2021, before exceptional costs, is expected to be above £3.5m on sales of around £77m. This is an improvement from previous market expectations and includes around £2.9m of the Coronavirus Job Retention Scheme and Paycheck Protection Program government schemes.

This announcement contains information that would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

 

For further enquiries, please contact:

James Cropper PLC (AIM: CRPR)

Phil Wild, CEO

Isabelle Maddock, CFO

Tel: +44 (0) 1539 722002

www.jamescropper.com

 

 

Shore Capital

Robert Finlay, Henry Willcocks

John More

Tel: + 44 (0) 207 408 4050

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDKPBDCBKDCNK
Date   Source Headline
11th Nov 20147:00 amRNSHalf-year results to 27 September 2014
22nd Sep 20142:29 pmRNSDirector/PDMR Shareholding
8th Sep 201412:53 pmRNSExpansion of production capacity
22nd Aug 201410:44 amRNSAcquisition of shares by Share Incentive Plan
5th Aug 20144:51 pmRNSDirector/PDMR Shareholding
30th Jul 201411:00 amRNSAnnual General Meeting and Trading Update
21st Jul 20145:01 pmRNSDIRECTORS' SHAREHOLDINGS
11th Jul 201412:10 pmRNSDirector/PDMR Shareholding
4th Jul 201411:45 amRNSDirector/PDMR Shareholding
24th Jun 20147:00 amRNSFinal Results
5th Jun 20147:00 amRNSBoard changes
2nd Jun 20143:41 pmRNSTotal Voting Rights
6th May 20148:53 amRNSIssue of Equity
1st Apr 20147:00 amRNSIssue of Equity
31st Mar 20144:57 pmRNSTotal Voting Rights
4th Mar 20147:00 amRNSIssue of Equity
3rd Mar 20141:38 pmRNSHolding(s) in Company
28th Feb 201411:40 amRNSBoard Change
12th Feb 201410:42 amRNSIssue of Equity
7th Jan 20144:08 pmRNSHolding(s) in Company
2nd Jan 201410:56 amRNSTotal Voting Rights
2nd Jan 20147:00 amRNSBoard appointment
5th Dec 20139:48 amRNSIssue of Equity
5th Dec 20138:18 amRNSDIRECTORS' SHAREHOLDINGS
27th Nov 20137:00 amRNSIssue of Equity
15th Nov 20139:14 amRNSDirector Dealing
12th Nov 20137:00 amRNSHalf-year results to 28 September 2013
1st Oct 201310:07 amRNSHolding(s) in Company
20th Sep 20134:54 pmRNSDirector Dealing
17th Sep 20133:22 pmRNSDirector Dealing
17th Sep 20137:00 amRNSBoard appointment
7th Aug 201311:36 amRNSDirector Dealing
1st Aug 20137:00 amRNSDIRECTORS' SHAREHOLDINGS
31st Jul 201311:00 amRNSAnnual General Meeting and Trading Update
23rd Jul 20135:18 pmRNSDirector/PDMR Shareholding
17th Jul 20137:00 amRNSNew Recycling Technology Developed
4th Jul 20137:00 amRNSIssue of Equity
25th Jun 20137:00 amRNSPrelim Results for the year ended 30 March 2013
29th May 201311:46 amRNSBoard change
24th May 201311:27 amRNSBoard changes
2nd Apr 201312:42 pmRNSTotal Voting Rights
28th Mar 20137:00 amRNSIssue of Equity
20th Mar 201311:09 amRNSHolding(s) in Company
19th Mar 201311:31 amRNSDirector Shareholding
15th Mar 20137:00 amRNSIssue of Equity
8th Mar 20134:31 pmRNSHolding(s) in Company
5th Mar 20139:09 amRNSTotal Voting Rights
18th Feb 20133:59 pmRNSIssue of Equity
15th Nov 20123:10 pmRNSDirectorship Changes - Replacement
15th Nov 20123:09 pmRNSIssue of Equity & Director Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.